Increased Apoptotic Cell Death in Sporadic and Genetic Alzheimer's Disease

Abstract: Mounting evidence indicates increased susceptibility to cell death and increased oxidative damage as common features in neurons from sporadic Alzheimer's disease (AD) patients but also from familial AD (FAD) cases. Autosomal dominant forms of FAD are caused by mutations of the amyloid precursor protein (APP) gene and by mutations of the genes encoding for presenilin 1 or presenilin 2 (PS1/2). We investigated the effect of the Swedish APP double mutation (APPsw) on oxidative stress‐induced cell death mechanisms in PC12 cells. This mutation results in from three‐ to sixfold increased β‐amyloid (Aβ) production compared with wild‐type APP (APPwt). Because APPsw cells secrete low Aβ levels similar to the situation in FAD brains, our cell model represents a very suitable approach to elucidate the AD‐specific cell death pathways under more likely physiological conditions. We found that APPsw‐bearing cells show decreased mitochondrial membrane potential after exposure to hydrogen peroxide. In addition, activity of the executor caspase 3 after treatment with hydrogen peroxide was elevated in APPsw cells, which seems to be the result of an enhanced activation of both intrinsic and extrinsic apoptosis pathways. Our findings provide evidence that the massive neurodegeneration in early age of FAD patients could be a consequence of an increased vulnerability of neurons by mitochondrial abnormalities resulting in activation of different apoptotic pathways as a consequence to elevated oxidative stress levels. Finally, we propose a hypothetical sequence of the pathogenic steps linking sporadic AD, FAD, Aβ production, mitochondrial dysfunction with caspase pathway, and neuronal loss.

[1]  Oliver Wirths,et al.  Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice , 2001, Neuroscience Letters.

[2]  W. Markesbery,et al.  Increased DNA Oxidation and Decreased Levels of Repair Products in Alzheimer's Disease Ventricular CSF , 1999, Journal of neurochemistry.

[3]  C. Masters,et al.  Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides , 1997, Nature Medicine.

[4]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. D. Ehmann,et al.  Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease , 1997, Neurobiology of Aging.

[7]  G. Salvesen,et al.  Caspases on the brain , 2002, Journal of neuroscience research.

[8]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[9]  Robert B. Petersen,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[10]  M. Schapiro,et al.  Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Haass,et al.  Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation , 2001, Journal of neuroscience research.

[12]  C. Luckhaus,et al.  Alzheimer's Disease-like Alterations in Peripheral Cells from Presenilin-1 Transgenic Mice , 2001, Neurobiology of Disease.

[13]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[14]  C. Cotman,et al.  Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons , 1994, Brain Research.

[15]  C. Cotman,et al.  Enhanced vulnerability to apoptotic cell death in sporadic Alzheimer's disease , 1998, Neuroreport.

[16]  S. Rabacchi,et al.  Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid , 2000, The Journal of Neuroscience.

[17]  C. Cotman,et al.  DNA Damage and Activated Caspase-3 Expression in Neurons and Astrocytes: Evidence for Apoptosis in Frontotemporal Dementia , 2000, Experimental Neurology.

[18]  William H. Nesse,et al.  Activation of Caspase-8 in the Alzheimer's Disease Brain , 2001, Neurobiology of Disease.

[19]  T. Hartmann,et al.  Intracellular biology of Alzheimer’s disease amyloid beta peptide , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[20]  D. Vaux,et al.  A Cinderella Caspase Takes Center Stage , 2002, Science.

[21]  H. Vinters,et al.  Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. , 1998, The American journal of pathology.

[22]  M. Hennerici,et al.  Elevated Levels of Fragmented DNA Nucleosomes in Native and Activated Lymphocytes Indicate an Enhanced Sensitivity to Apoptosis in Sporadic Alzheimer’s Disease , 2001, Dementia and Geriatric Cognitive Disorders.

[23]  S. Leutner,et al.  Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations , 2000, Neuroscience Letters.

[24]  C. Cotman,et al.  Up‐regulation of Bcl‐2 is associated with neuronal DNA damage in Alzheimer's disease , 1996, NeuroReport.

[25]  C. Cotman,et al.  Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain , 2002, Neurobiology of Disease.